跳至主要内容
MedPath Trial logoMedPath TrialMedPath Trial Home
临床试验/CTRI/2022/12/047995
CTRI/2022/12/047995尚未招募3 期

Randomized, multi-centric trial of Oral Metronomic Maintenance Therapy (OMMT) vs Capecitabine (Cape) maintenance in newly diagnosed, locally advanced and/or node positive, non-metastatic triple negative breast cancer (TNBC) patients after the completion of standard therapy along with an exploratory study to assess if circulating tumor DNA (ctDNA) and/or circulating tumor cells (CTCs) can be used as a biomarker to predict the probability of recurrence.

Tata Memorial Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

试验速览

阶段
3 期
状态
尚未招募
研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • •1. Non metastatic locally advanced or node positive TNBC
  • •2. Eastern cooperative oncology group performance status 0-2
  • •3. Within 1 month of completion of Standard Therapy consisting of Chemotherapy (Anthracycline & Taxane based); Surgery; +/- RT
  • •4. Able to understand and sign informed consent form

排除标准

  • •1. Synchronous or metachronous malignancy
  • •2. Uncontrolled comorbidities
  • •3. Pregnancy and lactation
  • •4. Patient who have not received standard therapy for TNBC or are referred > 1 month after completion of standard therapy

研究者

相似试验

进行中（未招募）
1 期
A clinical study comparing the combination of oral chemotherapy medications vinorelbine plus cyclophosphamide and capecitabine taken orally at lower doses on a continuous regular schedule with paclitaxel given by injection once a week in patients with advanced breast cancer or breast cancer that has spread to other body systems.
EUCTR2016-002200-39-ITInternational Breast Cancer Study Group (IBCSG)160
进行中（未招募）
1 期
DK378 versus chemotherapy in previously untreated patients with ALK rearranged non-small cell lung cancer
EUCTR2013-000319-26-NLovartis Pharma Services AG346
进行中（未招募）
不适用
DK378 versus chemotherapy in previously untreated patients with ALK rearranged non-small cell lung cancer
EUCTR2013-000319-26-ITOVARTIS FARMA S.p.A.346
进行中（未招募）
1 期
DK378 versus chemotherapy in previously untreated patients with ALK rearranged non-small cell lung cancer
EUCTR2013-000319-26-ESovartis Farmacéutica, S.A.346
进行中（未招募）
3 期
A clinical research study to find out if the drug LDK378 is safe and has beneficial effects in people who have a particular type of lung cancer called â??ALK positiveâ?? non-small cell lung cancer.
CTRI/2014/07/004753ovartis Healthcare Pvt Ltd